Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

384

HTML

2792

Tables (1-6)

217

Sum=3393

Mar 14, 2012 (publication date) through Nov 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 14, 2012; 18(10): 1021-1027
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1021

Table 3 Manometric data before, and 1 and 2 mo after botulinum toxin treatment (mean ± SD)

Time	Resting anal pressure (mmHg)	Maximum voluntary anal squeeze pressure (mmHg)
Baseline	107.1 ± 20.0	78.2 ± 17.0
1 mo	84.4 ± 23.6^b	70.9 ± 18.3^a
2 mo	82.3 ± 22.7^b	70.1 ± 19.2

All patients were included in all evaluations.

^aP = 0.036,

^bP < 0.001 vs baseline.

Citation: Vanella S, Brisinda G, Marniga G, Crocco A, Bianco G, Maria G. Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity. World J Gastroenterol 2012; 18(10): 1021-1027
URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1021.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1021